Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with PRAX: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
PRAX
Praxis Precision Medicines, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
PRAX
Praxis Precision Medicines, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
PRAX
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±9.4%
▲
+15.95%
×1.69
Q1 FY26
±7.4%
▼
−0.98%
×0.14
= implied
LLY realized, solid
PRAX realized, hatched
One scale, both sides: full bar = 16%
× = |realized| ÷ implied
Source: market data
Feb 19 '26
±7.3%
▲
+0.81%
×0.11
Q3 FY25
±12.1%
▼
−4.14%
×0.34
LLY
ELI Lilly & Co
Change
1,404.11
▼
−0.95%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
PRAX
Praxis Precision Medicines, Inc.
Change
276.08
▼
−3.44%
Regular session
Nov 2 '26
Mkt cap
$8.0B
Revenue
$7M
Q4 FY24
Revenue
$9M
FY24
vs
Compare
Regular session
Nov 2 '26
LLY
ELI Lilly & Co
vs
PRAX
Praxis Precision Medicines, Inc.
1,404.11
▼
−0.95%
Price
276.08
▼
−3.44%
$1.3T
Mkt cap
$8.0B
Q3 FY26
$24.4B
Revenue
$7M
Q4 FY24
FY25
$65.2B
Revenue
$9M
FY24
Change
Change
LLY
1,404.11
▼
−0.95%
vs
PRAX
276.08
▼
−3.44%
Regular session
Nov 2 '26